Jessica Hagen
The company will use the funds to expand its workforce, including its sales team, in order to broaden its biopharma partnerships.
The funding comes a year after the company announced an expanded relationship with OpenAI to develop a chatbot for healthcare providers built on GPT-4.
During the Galaxy Unpacked event in Paris today, the company announced its updated smartwatch and a new ring wearable with AI-enabled health features.
The company will use the investment to expand its reach across the U.S. and develop new technologies.
The acquisition allows Uwill to provide access to mental health support to more than three million students at 400 colleges worldwide.
Antidote will use SEQSTER's operating system to improve clinical trial time lines and enhance patient engagement for pharma and life sciences companies.
The company will build a genAI-enabled expert health coach that personalizes behavioral change.
mCareWatch 241 aims to allow individuals who may need emergency assistance, like those with disabilities or senior citizens, to access the help they need quickly.
The virtual care company will be directly available to patients experiencing menopause and perimenopause or via a Keck Medicine of USC-affiliated provider.
The company's first two partners to leverage OMNY's dataset are life sciences company ArisGlobal and clinical trial design company QuantHealth.